Melatonin and angiogenesis potential in stem cells
Rashidi S., Chegeni SA., Roozbahani G., Rahbarghazi R., Rezabakhsh A., Reiter RJ.
Narrative Review on Cardiovascular Disease, Chronic Inflammation, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Stem Cell Res Ther (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 40764577
- PMCID
- PMC12326606
- DOI
- 10.1186/s13287-025-04531-y
- Citations
- 1
Abstract (original English)
Ischemic diseases, especially coronary artery diseases and myocardial infarction, are the leading cause of human death in the clinical setting. Unfortunately, most of the available clinical interventions can partially restore the function of ischemic myocardium, resulting in the progression of chronic heart failure.The induction of vascular tissue formation, hereafter known as angiogenesis, can provide blood perfusion and prevent the expansion of ischemia-related pathologies. In recent years, the discovery and advent of multiple stem cells into human regenerative medicine have led to the alleviation of certain end-stage pathological conditions via direct differentiation into the mature and functional cells or secretion of various cytokines and angiogenesis factors in a paracrine manner. Melatonin (mel) is a natural molecule with direct and indirect pleiotropic actions on different biological phenomena. This neurohormone is primarily known for its antioxidant, tumoricidal, and anti-inflammatory actions in several pathological conditions. Whether and how mel regulates the angiogenesis behavior of stem cells is currently under debate. Here, we collected and evaluated recent data related to the angiogenic properties of mel on stem cells. Data from the present article may help us in the development of new therapeutic regimes in patients with ischemic conditions.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
Factor XII-A New Therapeutic Target? A Systematic Review
Systematic Review on Cardiovascular Disease, Neuroinflammation, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci1 citations - Level AMeta-analysisEurope PMC
Can cell-based therapies bridge the gap between research and reality in the treatment of myocarditis? A systematic review and meta-analysis
Meta-analysis on Cardiovascular Disease, published in Regen Ther (2026) — summary generated from the PubMed abstract.
- 2026
Regen Ther - Level AMeta-analysisEurope PMC
Efficacy and safety of stem cell therapy for myocardial infarction and heart failure: an updated systematic review and meta-analysis of randomized controlled trials
Meta-analysis with a reported sample of 3345 on Cardiovascular Disease, Stroke Research, published in Syst Rev (2026) — summary generated from the PubMed abstract.
- 2026
- n = 3345
Syst Rev - Level AMeta-analysisEurope PMC
Orally derived mesenchymal stem cells in the treatment of vascular diseases: a systematic review and meta-analysis
Meta-analysis on Cardiovascular Disease, published in Sci Rep (2026) — summary generated from the PubMed abstract.
- 2026
Sci Rep - Level ASystematic ReviewEurope PMC
From Preservation to Repair: A Systematic Review of Therapeutic Organ Rehabilitation During Normothermic Ex Vivo Machine Perfusion
Systematic Review with a reported sample of 12 on Cardiovascular Disease, Immune Modulation, published in Transplant Direct (2026) — summary generated from the PubMed abstract.
- 2026
- n = 12
Transplant Direct - Level AMeta-analysisEurope PMC
Safety and Efficacy of Transendocardial Stem Cells Therapy in Chronic Ischemic Heart Failure: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Meta-analysis on Cardiovascular Disease, Stroke Research, published in Curr Cardiol Rev (2025) — summary generated from the PubMed abstract.
- 2025
Curr Cardiol Rev